ADCT

Adc Therapeutics Stock Analysis

AI Rating

Good
  • Quality3/10
  • Growth↑ 7/10
  • Momentum↑ 8/10
Adc Therapeutics sales and earnings growth
ADCT Growth
Good
  • Revenue Y/Y↑ 6.35%
  • EPS Y/Y↑ 40.42%
  • FCF Y/Y↓ 1.83%
Adc Therapeutics gross and profit margin trends
ADCT Profitability
Fair
  • Gross margin ↑ 92.70%
  • EPS margin↓ -222.00%
  • ROIC↓ -97.80%
Adc Therapeutics net debt vs free cash flow
ADCT Risk
Great
  • Debt / Equity↓ -0.5
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -2.3

Adc Therapeutics stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗